
Sintx Technologies SINT
$ 2.73
-2.15%
Quarterly report 2025-Q3
added 11-12-2025
Country |
|
IPO year |
2014 |
Industry |
Medical devices |
Stock Exchange |
NASDAQ CAPITAL |
Shares |
3.74 M |
Market Cap[1] |
$ 10.2 M |
EBITDA (LTM) |
$ -11.2 M |
P/E (LTM) |
-0.22 |
P/S (LTM) |
6.83 |
EPS (LTM) |
-12.62 |
Other stocks of industry "Medical devices"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Acutus Medical
AFIB
|
- | -26.83 % | $ 2.62 M | Nasdaq Global Select Market | ||
|
Allied Healthcare Products
AHPI
|
- | 3.58 % | $ 2.21 M | Nasdaq Capital Market | ||
|
Alphatec Holdings
ATEC
|
$ 12.4 | -4.62 % | $ 1.86 B | Nasdaq Global Select Market | ||
|
GenMark Diagnostics, Inc.
GNMK
|
- | - | $ 1.77 B | Nasdaq Global Select Market | ||
|
Aziyo Biologics
AZYO
|
- | 1.37 % | $ 20.5 M | Nasdaq Global Market | ||
|
Lianluo Smart Limited
LLIT
|
- | 24.59 % | $ 44.8 M | Nasdaq Global Select Market | ||
|
Electromed
ELMD
|
$ 24.2 | -0.37 % | $ 205 M | NYSE American | ||
|
Obalon Therapeutics, Inc.
OBLN
|
- | -5.86 % | $ 30.6 M | Nasdaq Capital Market | ||
|
Bruker Corporation
BRKR
|
$ 38.9 | 1.04 % | $ 5.8 K | Nasdaq Global Select Market,SPB | ||
|
FONAR Corporation
FONR
|
$ 18.47 | -0.35 % | $ 121 M | Nasdaq Capital Market | ||
|
Cognyte Software Ltd.
CGNT
|
$ 8.26 | 0.85 % | $ 593 M | Nasdaq Global Select Market,SPB | ||
|
Conformis
CFMS
|
- | - | $ 16.4 M | Nasdaq Capital Market | ||
|
AdaptHealth Corp.
AHCO
|
$ 9.48 | -1.96 % | $ 1.28 B | Nasdaq Capital Market | ||
|
Apollo Endosurgery
APEN
|
- | - | $ 475 M | Nasdaq Global Market | ||
|
Cardiovascular Systems
CSII
|
- | 0.15 % | $ 844 M | Nasdaq Global Select Market,SPB | ||
|
CONMED Corporation
CNMD
|
$ 41.76 | -2.86 % | $ 1.3 B | NYSE,SPB | ||
|
EDAP TMS S.A.
EDAP
|
$ 4.17 | -2.0 % | $ 155 M | Nasdaq Global Market | ||
|
Cutera
CUTR
|
- | -10.19 % | $ 1.99 M | Nasdaq Global Select Market | ||
|
CryoLife, Inc.
CRY
|
- | -4.14 % | $ 702 M | NYSE,SPB | ||
|
Avinger
AVGR
|
- | -20.74 % | $ 369 K | Nasdaq Capital Market | ||
|
CHF Solutions, Inc.
CHFS
|
- | 1.15 % | $ 34.5 M | Nasdaq Capital Market | ||
|
AxoGen
AXGN
|
$ 28.74 | -1.64 % | $ 1.32 B | Nasdaq Capital Market,SPB | ||
|
Apyx Medical Corporation
APYX
|
$ 3.19 | -3.48 % | $ 110 M | Nasdaq Global Select Market | ||
|
Axonics Modulation Technologies
AXNX
|
- | - | $ 3.31 B | Nasdaq Global Select Market,SPB | ||
|
Dynatronics Corporation
DYNT
|
- | 14.99 % | $ 929 K | Nasdaq Capital Market | ||
|
Pulmonx Corporation
LUNG
|
$ 1.62 | 12.15 % | $ 63.4 M | Nasdaq Global Select Market | ||
|
Eargo
EAR
|
- | - | $ 10.2 M | Nasdaq Global Select Market,SPB | ||
|
Soliton, Inc.
SOLY
|
- | -1.42 % | $ 435 M | Nasdaq Global Select Market | ||
|
Medtronic PLC
MDT
|
$ 92.73 | -3.0 % | $ 119 B | NYSE,SPB | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
- | -1.98 % | $ 98.3 M | Nasdaq Capital Market | ||
|
Itamar Medical Ltd.
ITMR
|
- | 0.03 % | $ 1.58 B | Nasdaq Global Select Market | ||
|
Second Sight Medical Products
EYES
|
- | -0.97 % | $ 54.4 M | Nasdaq Capital Market | ||
|
Accuray Incorporated
ARAY
|
$ 0.51 | -2.26 % | $ 52.4 M | Nasdaq Global Select Market | ||
|
Misonix, Inc.
MSON
|
- | - | $ 462 M | Nasdaq Global Select Market | ||
|
Neovasc
NVCN
|
- | - | $ 111 M | Nasdaq Capital Market | ||
|
Cytosorbents Corporation
CTSO
|
$ 0.81 | 1.9 % | $ 44.1 M | Nasdaq Capital Market | ||
|
Align Technology
ALGN
|
$ 176.03 | -3.37 % | $ 13.2 B | Nasdaq Global Select Market,SPB | ||
|
Intersect ENT, Inc.
XENT
|
- | - | $ 955 M | Nasdaq Global Market | ||
|
Butterfly Network
BFLY
|
$ 3.65 | -9.55 % | $ 773 M | NYSE | ||
|
BIOLASE
BIOL
|
- | -13.19 % | $ 166 K | Nasdaq Capital Market | ||
|
Abbott Laboratories
ABT
|
$ 111.27 | -1.62 % | $ 194 B | NYSE,SPB | ||
|
Orthofix Medical
OFIX
|
$ 12.59 | -2.18 % | $ 499 M | Nasdaq Global Select Market,SPB | ||
|
InMode Ltd.
INMD
|
$ 13.45 | -0.81 % | $ 869 M | Nasdaq Global Select Market,SPB | ||
|
BioSig Technologies
BSGM
|
- | 37.08 % | $ 85.7 M | Nasdaq Global Select Market | ||
|
Boston Scientific Corporation
BSX
|
$ 71.38 | -1.15 % | $ 106 B | NYSE,SPB | ||
|
PAVmed
PAVM
|
$ 10.1 | -3.81 % | $ 73 M | Nasdaq Capital Market | ||
|
IRadimed Corporation
IRMD
|
$ 100.14 | -4.73 % | $ 1.27 B | Nasdaq Global Select Market | ||
|
Insulet Corporation
PODD
|
$ 239.64 | -1.34 % | $ 16.9 B | Nasdaq Global Select Market,SPB | ||
|
IRIDEX Corporation
IRIX
|
$ 1.4 | -0.71 % | $ 22.6 M | Nasdaq Global Select Market | ||
|
Profound Medical Corp.
PROF
|
$ 7.17 | -4.21 % | $ 180 M | Nasdaq Global Select Market |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.